Lung Neoplasms: all 7,334 studies
Page 34 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 InhibitorsStatus unknownNCT05460481Phase 2
- Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD EvaluationStatus unknownNCT05460195Phase 2
- Meaning of Recovery After Lung Cancer SurgeryStatus unknownNCT05453812
- A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based ChemotherapyActive, not recruitingNCT05450692Phase 3
- Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in PatientsCompletedNCT05450081
- Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLCStatus unknownNCT05448781Phase 2
- Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC RegimenTerminatedNCT05443971Phase 1
- TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)Active, not recruitingNCT05441956Phase 1
- Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping MutationTerminatedNCT05435846Phase 1
- To Establish a Molecular Typing System for Early Diagnosis of Lung CancerStatus unknownNCT05432128
- A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung CancerStatus unknownNCT05431569Phase 2
- Immunological Variables Associated to ICI Toxicity in Cancer PatientsStatus unknownNCT05429866Phase 2
- A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung LesionsWithdrawnNCT05426213Not applicable
- Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung CancerStatus unknownNCT05425134
- Clinical Characteristics of Lung Cancer in ChinaStatus unknownNCT05423236
- A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 InsertionCompletedNCT05419700
- Assessment of Relationship Between Preoperative Nutritional Status and Perioperative/Postoperative Conditions in Patients With Lung Cancer Scheduled for LobectomyStatus unknownNCT05417672
- Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation TherapyStatus unknownNCT05414188Not applicable
- Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungWithdrawnNCT05412875Not applicable
- EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung CancerWithdrawnNCT05411679Phase 2
- A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2Status unknownNCT05411276
- Oral Iloprost for the Prevention of Lung Cancer In Former SmokersWithdrawnNCT05411107Phase 2
- Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation ToolActive, not recruitingNCT05407168Not applicable
- Remote Monitoring with Health-Coaching for Lifestyle Changes in Patients with Lung Cancer Related FatigueTerminatedNCT05407038Not applicable
- Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 YearsCompletedNCT05404022Not applicable
- Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCSuspendedNCT05403723Phase 1
- Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLCWithdrawnNCT05400577Phase 2
- Exhaled Breath Particles in Lung CancerStatus unknownNCT05395611
- Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine AdequacyCompletedNCT05393154
- Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung CancerActive, not recruitingNCT05384769Not applicable
- Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung CancerActive, not recruitingNCT05384015Phase 2
- Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT05380908
- A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung CancerStatus unknownNCT05380024Phase 2
- Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC PatientsCompletedNCT05375994Phase 1/2
- SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS MutationTerminatedNCT05375084Phase 1
- Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLCActive, not recruitingNCT05374603Phase 2
- Mass Balance Study of [14C]ChiauranibCompletedNCT05371899Not applicable
- Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted TherapiesActive, not recruitingNCT05370469Not applicable
- SCOOT: Sample Collection for DARTActive, not recruitingNCT05368298
- Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung CancerWithdrawnNCT05364645Phase 2
- Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-freeCompletedNCT05362318Not applicable
- A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions.Status unknownNCT05361564Phase 2
- First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)Active, not recruitingNCT05361395Phase 1
- Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR KitCompletedNCT05360225
- Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge ResectionCompletedNCT05358158Not applicable
- A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung CancerStatus unknownNCT05354700Phase 2
- A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128Active, not recruitingNCT05354102Phase 1
- Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR KitCompletedNCT05348187Not applicable
- Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR KitCompletedNCT05347797Not applicable
- Assessing the Safety and Efficacy of PLB1004 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT05347628Phase 1
- A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).Status unknownNCT05346952Phase 3
- Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery DownloadCompletedNCT05346380Phase 1/2
- Lung Cancer Surgery in Sarcopenia Patients With Old AgeActive, not recruitingNCT05346185
- A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung CancerCompletedNCT05342571Not applicable
- Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung CancerActive, not recruitingNCT05340309Phase 2
- Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT TrialCompletedNCT05339022Not applicable
- A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in ChinaCompletedNCT05337163
- Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsActive, not recruitingNCT05334329Phase 1
- Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic ExerciseStatus unknownNCT05332171Not applicable
- Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.CompletedNCT05331833
- A Mobile SMART Exercise Support Program to Improve Fatigue in Lung Cancer Patients - A RCTStatus unknownNCT05331391Not applicable
- A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung CancerActive, not recruitingNCT05329025Phase 2
- The Prediction Biomarkers of Survival Outcome for Severe Immune-related HepatitisCompletedNCT05326906
- Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.Status unknownNCT05326425Phase 2
- Pulmonary Rehabılıtatıon Wıth Non-Small Lung CancerStatus unknownNCT05320458Not applicable
- Personalised Diet, Exercise and Emotional Support for Lung Cancer Patients Having Chemotherapy, Radiotherapy or Immunotherapy TreatmentStatus unknownNCT05318807Not applicable
- A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung CancerCompletedNCT05318443Phase 3
- ChatBot and Activity Monitoring in Patients Undergoing ChemoradiotherapyActive, not recruitingNCT05318027Phase 2
- Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung CancerCompletedNCT05309629Phase 2
- CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in LungActive, not recruitingNCT05306288
- A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of SeattleTerminatedNCT05304390Not applicable
- Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRITerminatedNCT05302817Phase 1
- The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)Status unknownNCT05299385Phase 3
- Utidelone in Third-line and Above Treatment of Small Cell Lung CancerStatus unknownNCT05299255Phase 2
- Folic Acid Interferes With Radiation EsophagitisStatus unknownNCT05296369Not applicable
- Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural EffusionStatus unknownNCT05291403Not applicable
- irAE Prediction of Anti-PD-1/L1 in Lung CancerStatus unknownNCT05288569
- A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard TherapyStatus unknownNCT05287386Phase 2
- TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung CancerStatus unknownNCT05284994Phase 1/2
- Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative RadiotherapyCompletedNCT05283564Not applicable
- The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.Status unknownNCT05279521Not applicable
- A Study to Investigate LYL797 in Adults With Solid TumorsTerminatedNCT05274451Phase 1
- Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung CancerStatus unknownNCT05273814Phase 1
- Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest SurgeryActive, not recruitingNCT05267496Not applicable
- Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or ChemoradiotherapyStatus unknownNCT05267392Phase 1/2
- Improving Implementation of Lung Cancer Screening in Diverse Populations IICompletedNCT05265897Not applicable
- Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLCStatus unknownNCT05265650Phase 1/2
- Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung CancerStatus unknownNCT05257512Phase 1/2
- Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR MutationsActive, not recruitingNCT05256290Phase 1/2
- DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTSActive, not recruitingNCT05254119
- An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownNCT05252091Phase 2
- Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung CancerStatus unknownNCT05252065
- Vertebral Marrow Attention Trial (VMAT)CompletedNCT05248256Not applicable
- An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in ChineseStatus unknownNCT05245994Phase 2
- Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLCStatus unknownNCT05243355Phase 2
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsTerminatedNCT05241873Phase 1
- A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).Active, not recruitingNCT05240131Phase 1/2
- Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung CancerActive, not recruitingNCT05237453Not applicable
- PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsTerminatedNCT05233436Phase 1